Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1588875

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1588875

Membrane Chromatography

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Membrane Chromatography Market to Reach US$1.0 Billion by 2030

The global market for Membrane Chromatography estimated at US$395.9 Million in the year 2023, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 14.2% over the analysis period 2023-2030. Ion Exchange Technique, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$492.2 Million by the end of the analysis period. Growth in the Affinity Technique segment is estimated at 15.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$102.2 Million While China is Forecast to Grow at 18.5% CAGR

The Membrane Chromatography market in the U.S. is estimated at US$102.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$252.1 Million by the year 2030 trailing a CAGR of 18.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.6% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Membrane Chromatography Market - Key Trends and Drivers Summarized

Why Is Membrane Chromatography Gaining Popularity in Bioprocessing?

Membrane chromatography is increasingly becoming a vital component in the bioprocessing sector, primarily due to its ability to streamline purification processes in the production of biopharmaceuticals. Unlike traditional column chromatography, membrane chromatography offers faster processing times and higher throughput, making it ideal for large-scale biomanufacturing. This technique involves the use of membranes with specific ligand interactions that capture target molecules, such as proteins or viruses, from a mixture, allowing for efficient purification. Its growing importance is linked to the rise in demand for monoclonal antibodies, vaccines, and gene therapies, all of which require high levels of purification.

What Are the Key Innovations in Membrane Chromatography?

Recent innovations in membrane chromatography include the development of high-capacity and high-flow membranes that reduce processing time while increasing efficiency. The latest generation of membrane adsorbers, which are capable of handling large volumes, are designed to provide superior binding capacities and minimize the risk of fouling. Additionally, advancements in ligand chemistry have led to more selective membranes, capable of isolating specific biomolecules with higher purity levels. Single-use membrane chromatography systems are also becoming more common, offering cost-effectiveness and eliminating the need for cleaning and validation between batches, making them highly appealing in the biopharmaceutical industry.

How Do Market Segments Define the Growth of Membrane Chromatography?

Product types include ion exchange membranes, affinity membranes, and hydrophobic interaction membranes, with ion exchange membranes holding the largest market share due to their wide applicability in protein purification. Operation modes include flow-through and bind-and-elute, with the flow-through mode gaining popularity for its efficiency in removing impurities during downstream processing. End-users of membrane chromatography systems include biopharmaceutical companies, research institutes, and contract research organizations (CROs), with biopharmaceutical companies being the dominant segment due to the rising production of biologics.

What Factors Are Driving the Growth in the Membrane Chromatography Market?

The growth in the membrane chromatography market is driven by several factors, including the increasing demand for biologics and biosimilars, advancements in bioprocessing technologies, and the rising focus on single-use technologies in manufacturing. Biopharmaceutical companies are under pressure to develop faster, more efficient purification methods, and membrane chromatography offers a viable solution. The growing trend towards continuous manufacturing and the use of single-use systems in bioprocessing is also contributing to the adoption of membrane chromatography. Furthermore, regulatory agencies are encouraging innovations that improve the efficiency and safety of biopharmaceutical production, further fueling market growth.

Select Competitors (Total 34 Featured) -

  • 3M
  • Asahi Kasei Corporation
  • Cole-Parmer Instrument Company, LLC
  • Danaher
  • General Electric
  • GL Sciences Inc.
  • GVS Group
  • Membrane Solutions
  • Merck KGaA
  • Purilogics LLC
  • Restek Corporation
  • Sartorius AG
  • STARLABS
  • Thermo Fisher Scientific Inc.
Show more
Product Code: MCP22250

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Membrane Chromatography - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biopharmaceutical Purification Drives Growth in Membrane Chromatography Market
    • Technological Advancements in Single-Use and Disposable Chromatography Systems Strengthen Business Case for Adoption
    • Growing Focus on Enhancing Efficiency and Reducing Process Time Expands Addressable Market
    • Expansion of Membrane Chromatography in Vaccine Production and Gene Therapy Fuels Market Growth
    • Increasing Adoption of Membrane Chromatography in Large-Scale Bioprocessing Expands Market Opportunities
    • Technological Innovations in High-Capacity and High-Throughput Membranes Propel Market Expansion
    • Growing Use of Membrane Chromatography in Monoclonal Antibody (mAb) Purification Expands Market Potential
    • Rising Adoption of Continuous Bioprocessing Solutions Expands Addressable Market for Membrane Chromatography
    • Technological Advancements in High Selectivity and Low Fouling Membranes Propel Market Growth
    • Increasing Focus on Reducing Contaminants and Impurities in Bioprocessing Drives Demand for Membrane Chromatography
    • Rising Use of Membrane Chromatography in Emerging Biopharma Markets Expands Market Opportunities
    • Expansion of Membrane Chromatography in Cell and Gene Therapy Manufacturing Strengthens Global Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Membrane Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Membrane Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Membrane Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Ion Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Ion Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Ion Exchange by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Affinity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Affinity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Affinity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hydrophobic Interaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hydrophobic Interaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hydrophobic Interaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Flow-Through by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Flow-Through by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Flow-Through by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Bind-Elute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Bind-Elute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Bind-Elute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Membrane Chromatography Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • JAPAN
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • CHINA
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • EUROPE
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Membrane Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Membrane Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Membrane Chromatography by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • FRANCE
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • GERMANY
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Membrane Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Membrane Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Membrane Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • INDIA
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Membrane Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Membrane Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Membrane Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Membrane Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Membrane Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Membrane Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030
  • AFRICA
    • Membrane Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Membrane Chromatography by Technique - Ion Exchange, Affinity and Hydrophobic Interaction Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Membrane Chromatography by Technique - Percentage Breakdown of Value Sales for Ion Exchange, Affinity and Hydrophobic Interaction for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Membrane Chromatography by End-Use - Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Membrane Chromatography by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Membrane Chromatography by Operation Mode - Flow-Through and Bind-Elute Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Membrane Chromatography by Operation Mode - Percentage Breakdown of Value Sales for Flow-Through and Bind-Elute for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!